(Q50957777)

26 March 2018

title

Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity. (English)

1 reference

26 March 2018

1 reference

1 reference

Ricardo Machado Xavier

9

1 reference

26 March 2018

author name string

V R da Cunha

1

1 reference

26 March 2018

C V Brenol

2

1 reference

26 March 2018

J C T Brenol

3

1 reference

26 March 2018

S C Fuchs

4

1 reference

26 March 2018

E M Arlindo

5

1 reference

26 March 2018

I M F Melo

6

1 reference

26 March 2018

C A Machado

7

1 reference

26 March 2018

H de Castro Chaves

8

1 reference

26 March 2018

publication date

15 March 2012

1 reference

26 March 2018

Scandinavian Journal of Rheumatology

published in

1 reference

26 March 2018

volume

41

1 reference

26 March 2018

issue

3

1 reference

26 March 2018

page(s)

186-191

1 reference

26 March 2018

Epidemiology of adult rheumatoid arthritis

cites work

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.626443

Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.626443

Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.626443

Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.626443

Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.626443

Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.626443

Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.626443

Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.626443

Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.626443

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.626443

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.626443

Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.626443

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.626443

Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.626443

The metabolic syndrome is amplified in hypothyroid rheumatoid arthritis patients: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.626443

Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.626443

Resistin is linked to inflammation, and leptin to metabolic syndrome, in women with inflammatory arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.626443

Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.626443

Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.626443

10.3109/03009742.2011.626443

21 January 2018

Identifiers

DOI

1 reference

26 March 2018

PubMed ID

22416768

1 reference

26 March 2018